the impact of novel therapies on cardiovascular treatment-related adverse events
Published 5 months ago • 30 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
1:34
managing adverse events with novel therapies in lower-risk mds
-
1:33
the impact of novel targeted & immune therapies in leukemia
-
2:43
novel therapies in the future of mds treatment
-
2:57
novel targeted therapies for the treatment of bpdcn
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:39
challenges associated with the use of novel gvhd therapies in clinical practice
-
0:57
novel therapeutic strategies in all
-
4:48
managing and treating mds
-
9:25
mgus diagnosis: a step-by-step approach
-
4:02
hannah’s story - living with hattr amyloidosis
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
2:34
the burden of vte in cancer patients: impacts and novel treatments
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:25
analyzing aml: novel therapies in review
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
2:00
associated toxicities of novel therapies for cll
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
1:41
novel therapies for high-risk mds
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
1:11
exciting updates in all and the value of novel immunotherapies